Studies on Synthesis of New Territrem B Analogues and Their Biological Activities

O Lei;JING Xing-rui;LI Dong-sheng;DONG Sheng-yi;OU YNG Ying-hu;I Hu;ZHO Yu

Chinese Pharmaceutical Journal ›› 2006, Vol. 41 ›› Issue (18) : 1423-1427.

Chinese Pharmaceutical Journal ›› 2006, Vol. 41 ›› Issue (18) : 1423-1427.
论著

Studies on Synthesis of New Territrem B Analogues and Their Biological Activities

  • AO Lei1, JIANG Xiang-rui1,2, LI Dong-sheng2, DONG Sheng-yi1, OU YANG Ying-hua1, BAI Hua3, ZHAO Yu1
Author information +
History +

Abstract

OBJECTIVE To study the design and synthesis of new territrem B analogues and their biological evaluation.METHODS New territrem B analogues 10a~10l with the common structure of 2H-pyran-2-one were designed and synthesized from ethyl acetoacetate.The cytotoxicities and inhibitory activities on acetylcholinesterase and butylcholinesterase of these synthetic analogues were examined by MTT and ELISA methods,respectively.RESULTS New analogues of territrem B were afforded and the structures were confirmed by 1H-NMR,ESI-MS and IR spectra.Compound 10f showed IC50 value to acetylcholinesterase at 6.98×10-5 mol·L-1 and all target compounds showed no inhibition to butylcholinesterase at 4.0 g·L-1.CONCLUSION The bioassay results indicated that 10f exhibited potential AChE inhibitory effect and better selectivity of AChE.

Key words

new territrem B analogues / 2H-pyran-2-one / acetylcholinesterase inhibitor / synthesis

Cite this article

Download Citations
O Lei;JING Xing-rui;LI Dong-sheng;DONG Sheng-yi;OU YNG Ying-hu;I Hu;ZHO Yu. Studies on Synthesis of New Territrem B Analogues and Their Biological Activities [J]. Chinese Pharmaceutical Journal, 2006, 41(18): 1423-1427

References

[1] LING K H, YANG C K, PENG F T. Territrems, tremorgenic mycotoxins of Aspergillus terreus[J] . Environ Microbiol, 1979, 37(3):355-357. [2] LING K H, LIOU H H, YANG C M, et al. Isolation, chemical structure, acute toxicity, and some physicochemical properties of territrem C from Aspergillus terreus[J] . Environ Microbiol, 1984, 47(1):98-100. [3] HSUNG R P, COLE K P, ZEHNDER L R, et al. The total synthesis of(±)-arisugacin A[J] . Tetrahedron, 2003, 59(3):311-324. [4] OTOGURO K, KUNO F, OMURA S. Arisugacins, selective acetylcholinesterase inhibitors of microbial origin[J] . Pharmacol Ther, 1997, 76(1):45-54. [5] ZHAO Y, KU Y L, HAO X J, et al. Preparation of analogues of territrem B, a potent AChE inhibitor[J] . Tetrahedron, 2000, 56(45):8901-8913. [6] ZHAO J H, ZHAO F, WANG Y G, et al. Synthesis of A/B ring analogs of territrem B and evaluation of their biological activities[J] . Helv Chim Acta, 2004, 87(7):1832-1852. [7] STILES M, WOLF D, HUDSON G V, et al. Catalyst selectivity in the reactions of unsymmetrical ketones, reaction of butanone with benzaldehyde and p-nitrobenzaldehyde[J] . J Am Chem Soc, 1959, 81:628-632. [8] KROUS G A, LIU P. A racemic synthesis of the novel antibacterial agent juglomycin A[J] . Synth Commun,1996, 26(23):4501-4506. [9] NICOLAOU K C, CHAKRABOTY T K, DAINES R A, et al. Retro-synthetic and synthetic chemistry on ampho-tericin B synthesis of C(1)-C(20) and C(21)-C(38) fragments and construction of the 38-membered macrocycle[J] . J Chem Soc Chem Commun,1986, 10(5):413-416. [10] HASSNER A, VAZKEN A. Direct room temperature esterification of carboxylic acid[J] . Tetrahedron Lett,1978,19(46):4475-4478. [11] GIANCARLO F, MARCO F, ALESSANDRO M, et al. Microbial approach to chiral 2-thiozolyl γ-and δ-latones[J] . Tetrahedron Asymmetry, 1992, 3(1):107-114. [12] TIERRY J, DENIS H. Synthesis of tricyclopolyprenols via a redical addition and a steroselective elimination. Part I methodology[J] . Tetrahedron,1998,54(1):97-106. [13] GRUTTADAURHA M, APPRHLE C, NOTO R. Stereocontrolled approach to δ-and γ-lactones and 1,3-diols. The role of X-ion in the selenolactonization[J] . Tetrahedron Lett, 2002, 43(9):1669-1672. [14] ELLMAN G L, COURTNEY K D, ANDRES V, et al. A new and rapid colorimetric determination of acetylcholinesterase activity[J] . Biochem Pharmacol, 1961, 7(2):88-95. [15] EAGGER S A, LEVY R, SAHAKIAN B J. Tacrine in Alzheimer's disease[J] . Lancet,1991,337(8748):989-992. [16] DENNIS J S. Alzheimer's disease:genes, protein, and therapy[J] . Physiol Rev, 2001, 81(2):741-766.

Accesses

Citation

Detail

Sections
Recommended

/